A US Industry Perspective
Alan Goldhammer and Jeff Trewhitt of PhRMA talk to Karen Finn about new regulatory
requirements, DTC advertising and international harmonisation.
The Future of Medical Products Regulation: How Can Pharmaceutical Innovation
be Safeguarded?
Jon Lisman suggests there are lessons to be learned from the medical devices
sector.
Protocol Design Trends and Clinical Trial Performance
Kenneth Getz reports that changes in protocol design might be adversely affecting
clinical trial performance.